Updated:
Platinum Dermatology Partners
Platinum Dermatology Partners launched in 2014 with a physician partnership model designed to consolidate fragmented dermatology practices.
Platinum Dermatology Partners
Platinum Dermatology Partners launched in 2014 with a physician partnership model designed to consolidate fragmented dermatology practices. Albert Contento, the CEO, structured the firm around a shared-equity framework that allows member physicians to retain significant clinical autonomy and ownership while accessing centralized administrative and back-office support. The 2018 merger with West Dermatology, a legacy Southern California group with roots dating to the 1960s, doubled the platform's footprint overnight. The firm executes a classic healthcare-services roll-up strategy, acquiring and integrating established dermatology clinics into a single operating entity. Its focus spans general dermatology, Mohs surgery, and cosmetic dermatology services. The combined entity now reports over 250 providers operating across more than 100 clinic locations concentrated in California, Arizona, and Texas. A significant growth catalyst came in 2022 when Sun Capital Partners, a middle-market private equity firm, announced a strategic investment in the platform, providing capital to accelerate further acquisitions. In March 2024, Platinum Dermatology Partners announced a partnership with Texas Dermatology Specialists, adding four new locations in the Dallas-Fort Worth metroplex (per the firm, March 2024). The firm also operates the West Dermatology Research Center, which runs clinical trials for conditions including psoriasis, atopic dermatitis, and hidradenitis suppurativa. This research arm gives Platinum a structural pipeline to new biologic therapies before competitors and creates an additional revenue stream that is less dependent on patient visit volume than a traditional private practice. The partnership with Sun Capital — a firm that specializes in founder-led business transitions — signals a multi-stage ownership model that is uncommon in physician practice management. Rather than a simple buyout, the structure maintains a physician ownership layer alongside institutional capital, theoretically aligning incentives around both clinical quality and operational efficiency. This hybrid governance architecture is the firm's most notable structural differentiator in a specialty where PE-backed roll-ups often face tension between profit targets and clinical culture.
General information
Firm type
Asset Manager
Year founded
2014
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Dallas
Corporate office
Dallas, TX, United States
Principals
Albert A. Contento
Chief Executive Officer
Sector focus
Frequently asked questions
Who leads investment and operational strategy at Platinum Dermatology Partners?
Albert Contento serves as Chief Executive Officer and has overseen the firm's acquisition strategy since its 2014 launch. Sun Capital Partners became a strategic institutional investor in 2022 and likely holds board-level influence over major capital allocation decisions. Day-to-day integration of acquired practices falls to a centralized management team in Dallas.
How does the physician partnership model work at Platinum?
Rather than acquiring practices outright and converting physicians to employees, Platinum acquires a majority interest while physicians retain meaningful minority equity. This gives member clinics access to shared administrative infrastructure — billing, HR, IT, compliance, payer contracting — while preserving clinical autonomy and a culture of owner-operator accountability. The West Dermatology merger added a research-center revenue stream to that base model.
What is the relationship between Platinum Dermatology Partners and West Dermatology?
Platinum Dermatology Partners and West Dermatology merged in 2018, combining a then-newly formed consolidation platform with a well-established Southern California practice group dating to the 1960s. The combined entity continues to operate under both brand names in different regions while functioning as a single integrated management company from its Dallas headquarters.
What role does Sun Capital Partners play in the firm's strategy?
Sun Capital Partners announced a strategic investment in Platinum Dermatology Partners in 2022. The firm typically provides growth capital to founder-led businesses, which suggests Platinum is in a scale-up phase rather than a harvest phase. Sun Capital's track record in healthcare services indicates an eventual exit to a larger sponsor or strategic acquirer, though no timeline has been publicly disclosed.
Does Platinum Dermatology Partners operate clinical trials or only clinical services?
The West Dermatology Research Center, inherited through the 2018 merger, conducts clinical trials for dermatologic conditions including psoriasis, atopic dermatitis, hidradenitis suppurativa, and actinic keratosis. This research capability differentiates the platform from purely practice-management roll-ups and provides early access to new biologic and systemic therapies.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: